Kelley Kenneth J (CIK 0001291219)

Latest company ownership

Shares held
179,833
Last filed at
Apr 14, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 14, 2021 Apr 14, 2021 HALOZYME THERAPEUTICS, INC. Director Sell 41.3 -5,000 -2.71% ✓ $225K
Mar 1, 2021 Mar 1, 2021 HALOZYME THERAPEUTICS, INC. Director Sell 41.3 -5,000 -2.63% ✓ $226.7K
Feb 1, 2021 Feb 1, 2021 HALOZYME THERAPEUTICS, INC. Director Sell 41.3 -5,000 -2.57% ✓ $240.6K
Jan 4, 2021 Jan 4, 2021 HALOZYME THERAPEUTICS, INC. Director Sell 41.3 -5,000 -2.50% ✓ $214.6K
Dec 7, 2020 Dec 7, 2020 HALOZYME THERAPEUTICS, INC. Director Sell 17.5 -35,086 -14.94% ✗ $1.4M
Dec 2, 2020 Dec 2, 2020 HALOZYME THERAPEUTICS, INC. Director Sell 17.5 -31,792 -11.92% ✗ $1.3M
Nov 25, 2020 Nov 27, 2020 HALOZYME THERAPEUTICS, INC. Director Sell 20.0 -19,671 -6.87% ✗ $813.9K
Mar 19, 2020 Mar 19, 2020 HALOZYME THERAPEUTICS, INC. Director Buy 97.5 +52,629 23.40% ✗ $748.7K
Jun 18, 2015 Jun 22, 2015 HALOZYME THERAPEUTICS, INC. Director Sell 20.0 -20,000 -9.17% ✗ $420K
Mar 5, 2015 Mar 9, 2015 HALOZYME THERAPEUTICS, INC. Director Sell 20.0 -40,000 -17.03% ✗ $613.4K
Aug 27, 2012 Aug 28, 2012 HALOZYME THERAPEUTICS, INC. Director Buy 95.0 +20,000 15.38% ✗ $114K
May 14, 2012 May 16, 2012 HALOZYME THERAPEUTICS, INC. Director Buy 95.0 +20,000 18.18% ✗ $149.8K